Drugs / PSIL428
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04989972 | Sep 2022 → Jun 2023 | mixed anxiety and depressive disorder | Wake Network, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSIL428 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04989972 ↗ |